IGM Biosciences, Inc. (IGMS)
NASDAQ: IGMS · Real-Time Price · USD
1.130
0.00 (0.00%)
At close: May 9, 2025, 4:00 PM
1.110
-0.020 (-1.77%)
After-hours: May 9, 2025, 7:47 PM EDT
IGM Biosciences Stock Forecast
IGMS's stock price has decreased by -87.9% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 7 analysts with 12-month price forecasts for IGM Biosciences stock have an average target of 6.14, with a low estimate of 1.50 and a high estimate of 22. The average target predicts an increase of 443.36% from the current stock price of 1.13.
Analyst Consensus: Hold
* Price targets were last updated on Jan 10, 2025.
Analyst Ratings
The average analyst rating for IGM Biosciences stock from 8 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Buy | 3 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 7 | 7 | 7 | 7 | 7 |
| Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Sell → Hold Upgrades n/a | Sell → Hold | Upgrades | n/a | n/a | Jan 13, 2025 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $48 → $2 | Strong Buy → Hold | Downgrades | $48 → $2 | +76.99% | Jan 10, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $12 → $2 | Hold | Maintains | $12 → $2 | +76.99% | Jan 10, 2025 |
| Stifel | Stifel | Strong Buy → Hold Downgrades $27 → $2.5 | Strong Buy → Hold | Downgrades | $27 → $2.5 | +121.24% | Jan 10, 2025 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $20 → $1.5 | Buy → Hold | Downgrades | $20 → $1.5 | +32.74% | Jan 10, 2025 |
Financial Forecast
Revenue This Year
5.94M
from 2.68M
Increased by 121.76%
Revenue Next Year
8.72M
from 5.94M
Increased by 46.83%
EPS This Year
-1.07
from -3.24
EPS Next Year
-0.67
from -1.07
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 25.2M | 25.2M | 25.2M | ||
| Avg | 5.9M | 8.7M | 11.3M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 841.4% | 324.5% | 189.1% | ||
| Avg | 121.8% | 46.8% | 29.8% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.09 | -0.06 | -0.04 | ||
| Avg | -1.07 | -0.67 | -0.85 | ||
| Low | -1.98 | -2.24 | -2.68 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.